About PID

Primary immunodeficiencies (PIDs) are a group of more than 400 potentially serious disorders, that can lead to frequent or severe infections, swellings and autoimmune problems. PID symptoms often appear in childhood, but some can first occur in adults.

News

15 April 2020

The Australasian Society of Clinical Immunology and Allergy (ASCIA) has developed a webpage in response to the COVID-19 infectious respiratory disease outbreak caused by the most recently discovered coronavirus at www.allergy.org.au/members/covid-19.

The situation regarding COVID-19 is rapidly changing so the content of this webpage is reviewed on a daily basis and updated as required.

October 2019

ASCIA, the Australasian Society of Clinical Immunology and Allergy, is working together with patient organisations and other collaborators to develop a National Immunodeficiency Strategy, for both Australia and New Zealand. 

The National Immunodeficiency Strategy’s Mission is to improve the health and wellbeing of people with PIDs (primary immunodeficiencies) and minimise the burden on individuals, carers, health services and community.

Goals

The National Immunodeficiency Strategy’s Mission is to improve the health and wellbeing of people with PIDs (primary immunodeficiencies) and minimise the burden on individuals, carers, health services and community.


© National Immunodeficiency Strategy 2020Contact Us | Disclaimer | Privacy | Sitemap